DZ Bank’s Xenon Pharmaceuticals XENE Stock Holding History

DZ Bank’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-62,875	Closed	-$308K	–	1101
2018 Q1	$308K	Buy	+62,875	New	+$232K	﹤0.01%	866

Other funds holding XENE

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

DZ Bank's XENE Position: Q2 2018 in Review

DZ Bank sold out of Xenon Pharmaceuticals (XENE) in Q2 2018, closing a stake of 62,875 shares — an estimated $308K sold.

DZ Bank first reported a position in XENE in Q1 2018 and held it in 1 quarter. The position peaked at $308K in Q1 2018. 42 funds tracked by Wall St. Rank hold XENE as of Q2 2018.

DZ Bank reported no remaining Xenon Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 62,875 Xenon Pharmaceuticals shares in Q2 2018, an estimated $308K.
DZ Bank first reported a position in Xenon Pharmaceuticals in Q1 2018 and held it in 1 quarter.
DZ Bank's Xenon Pharmaceuticals position peaked at $308K in Q1 2018.
42 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.